Study Evaluating the Safety and Tolerability of RCT1100 in Healthy and PCD Subjects
Clinical trial NCT05737485 · COMPLETED
Trial details
- NCT number
- NCT05737485
- Sponsor
- ReCode Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-18
- Primary completion
- 2024-07-25
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.